,,ii  #aag? ,,congress  #b;d ,session   
,s4 #dbhh  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,may #ai 7legislative  
day1 ,may #ag71 #bjbb,mr4 ,lujn         
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to all[ manufactur]s &      
sponsors ( a drug to use alt]native te/+
 me?ods to animal te/+ to inve/igate !  
safety & effectiv5ess ( a biological    
product4  #a4 ,%ort title ,?is ,act may 
be cit$ z ! ,r$uc+ ,animal ,te/+ ,act4  
#b4 ,new approa* me?odologies ,item 7bb7
 ( section #cea7k77#b77;,a77i77,i7 ( !  
,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bfb7k77#b77;,a77i77,i77 is   
am5d$ to read z foll[s3  7bb7 an        
assessm5t ( toxicity 7:i* may rely on1  
or consi/ (1 a /udy or /udies describ$ 9
 item 7aa7 or 7cc772 &  4